Uterine Cancer PDX Models

Patient Derived Xenograft (PDX) models display a true representation of the human heterogeneity of gynecologic malignancies and provide the most accurate approach to predicting an agents efficacy prior to entering the clinic. The CrownBio uterine cancer PDX collection consists several models including ER+ and estrogen dependent models. More

Patient-derived xenografts (PDX) offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials.
CrownBio’s HuPrime® PDX collection well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL ID CANCER TYPE SUBTYPE models per page
UT14024 Uterine Cancer NA VIEW MODEL Details
UT14026 Uterine Cancer NA VIEW MODEL Details
UT3617 Uterine Cancer Endometrial VIEW MODEL Details
UT3759 Uterine Cancer Endometrial VIEW MODEL Details
UT3778 Uterine Cancer Endometrial VIEW MODEL Details
UT5317 Uterine Cancer Endometrial, (ER+) VIEW MODEL Details
UT5318 Uterine Cancer Endometrial, (ER-) VIEW MODEL Details
UT5319 Uterine Cancer Endometrial, (ER+) VIEW MODEL Details
UT5320 Uterine Cancer Endometrial, (ER-) VIEW MODEL Details
UT5321 Uterine Cancer Endometrial, (ER+) VIEW MODEL Details